Clinical Trial Update: Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating a fentanyl-propofol-EMLA anesthesia technique for bone marrow aspiration was terminated, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Disease

Drugs mentioned

• EMLA Cream (lidocaine 2.5% / prilocaine 2.5% topical cream)
• FENTANYL (FENTANYL)
• PROPOFOL (Propofol)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Bone Marrow Disease, Pain | Phase 3 | Status: TERMINATED | Results posted: 2010-03-19